Roger Adsett
Chief Operating Officer at INSMED INCORPORATED
Net worth: 4 M $ as of 30/03/2024
Profile
Roger Adsett is currently an Independent Director at Landos Biopharma, Inc. since 2022.
He is also currently serving as the Chief Operating Officer at Insmed, Inc. since 2016.
Previously, he worked at AstraZeneca PLC as the Director of Marketing & Brand from 1994 to 2005.
He also held the position of Marketing Director at AstraZeneca R & D Lund and Nexium, Inc. From 2005 to 2016, he worked at Shire Plc as the SVP and Head of Gastrointestinal & Internal Medicine.
Mr. Adsett completed his undergraduate degree at Bucknell University and holds an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INSMED INCORPORATED
0.10% | 11/01/2024 | 148,559 ( 0.10% ) | 4 M $ | 30/03/2024 |
LANDOS BIOPHARMA, INC.
-.--% | 22/05/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
Roger Adsett active positions
| Companies | Position | Start |
|---|---|---|
| INSMED INCORPORATED | Chief Operating Officer | 13/11/2019 |
| LANDOS BIOPHARMA, INC. | Director/Board Member | 07/03/2022 |
Former positions of Roger Adsett
| Companies | Position | End |
|---|---|---|
| SHIRE | Corporate Officer/Principal | 31/08/2016 |
| ASTRAZENECA PLC | Sales & Marketing | 30/09/2005 |
| Nexium, Inc. | Sales & Marketing | - |
| AstraZeneca R & D Lund | Sales & Marketing | - |
Training of Roger Adsett
| Bucknell University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| INSMED INCORPORATED | Health Technology |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Nexium, Inc. | Finance |
| AstraZeneca R & D Lund |
- Stock Market
- Insiders
- Roger Adsett
